We are live on !
Find out more
Prudential Financial Portfolio holdings
AUM
$91.8B
Turnover
13.23%
1-Year Est. Return
38.24%
This Fund
S&P 500
This Quarter Est. Return
+21.67%
1 Year Est. Return
+38.24%
3 Year Est. Return
+116.92%
5 Year Est. Return
+155.26%
10 Year Est. Return
+554.11%
AUM
$91.8B
AUM Growth
+$10.6B
(+13%)
Cap. Flow
-$112M
Cap. Flow % of AUM
Cap. Flow %
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
32.26%
Holding
2,616
New
215
Increased
1,225
Reduced
1,002
Closed
131
Avg Time Held
7.1
years
Top 10 Avg Time Held
4.8
years
Top 20 Avg Time Held
4.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PGIM AAA CLO ETF
PAAA
|
+$422M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$276M |
| 3 |
PGIM Ultra Short Bond ETF
PULS
|
+$236M |
| 4 |
iShares TIPS Bond ETF
TIP
|
+$216M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$194M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dimensional US Equity ETF
DFUS
|
+$342M |
| 2 |
iShares Russell 1000 Value ETF
IWD
|
+$146M |
| 3 |
NVIDIA
NVDA
|
+$143M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
+$139M |
| 5 |
Meta Platforms (Facebook)
META
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.27% |
| 2 | Technology | 24.7% |
| 3 | Financials | 8.11% |
| 4 | Industrials | 6.67% |
| 5 | Real Estate | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1376
BridgeBio Pharma
BBIO
$13.4B
| $2.12M | ﹤0.01% |
28,522
-86,870
| -75% | -$6.08M |
2023 Q3
11 quarters
|
|
1377
Inogen
INGN
$188M
| $2.12M | ﹤0.01% |
328,970
-40,100
| -11% | -$265K |
2024 Q2
8 quarters
|
|
1378
FTAI Aviation
FTAI
$15.9B
| $2.12M | ﹤0.01% |
7,821
-18,332
| -70% | -$4.61M |
2023 Q3
11 quarters
|
|
1379
Compass
COMP
$7.48B
| $2.11M | ﹤0.01% |
171,325
-346,570
| -67% | -$2.89M |
2022 Q2
16 quarters
|
|
1380
1st Source
SRCE
$2.1B
| $2.11M | ﹤0.01% |
25,891
+240
| +0.9% | +$17.9K |
2013 Q2
52 quarters
|
|
1381
LeMaitre Vascular
LMAT
$1.93B
| $2.11M | ﹤0.01% |
21,953
+345
| +2% | +$35.4K |
2016 Q3
39 quarters
|
|
1382
Interparfums
IPAR
$3.69B
| $2.1M | ﹤0.01% |
18,769
+190
| +1% | +$17.9K |
2013 Q2
52 quarters
|
|
1383
O-I Glass
OI
$994M
| $2.1M | ﹤0.01% |
217,770
+2,310
| +1% | +$21.7K |
2013 Q2
52 quarters
|
|
1384
Astrana Health
ASTH
$1.86B
| $2.09M | ﹤0.01% |
44,960
+1,030
| +2% | +$37.1K |
2021 Q2
20 quarters
|
|
1385
Vontier
VNT
$4.65B
| $2.09M | ﹤0.01% |
71,906
-40,036
| -36% | -$1.28M |
2020 Q4
22 quarters
|
|
1386
Innospec
IOSP
$2.43B
| $2.08M | ﹤0.01% |
25,529
+260
| +1% | +$20.6K |
2014 Q4
46 quarters
|
|
1387
Travere Therapeutics
TVTX
$4.72B
| $2.08M | ﹤0.01% |
36,550
-125,685
| -77% | -$5.57M |
2023 Q4
10 quarters
|
|
1388
Dentsply Sirona
XRAY
$1.88B
| $2.08M | ﹤0.01% |
195,649
+182,347
| +1,371% | +$1.99M |
2013 Q2
52 quarters
|
|
1389
Lineage Inc
LINE
$8.05B
| $2.08M | ﹤0.01% |
+47,988
| New | +$1.89M |
2026 Q2
0 quarters
|
|
1390
Medical Properties Trust
MPT
$1.61B
| $2.07M | ﹤0.01% |
448,203
-3,200
| -0.7% | -$15.9K |
2013 Q2
52 quarters
|
|
1391
Synaptics
SYNA
$4.66B
| $2.06M | ﹤0.01% |
16,599
-1,175
| -7% | -$133K |
2013 Q2
52 quarters
|
|
1392
Stewart Information Services
STC
$1.35B
| $2.06M | ﹤0.01% |
31,191
+355
| +1% | +$23.7K |
2013 Q2
52 quarters
|
|
1393
Douglas Emmett
DEI
$1.7B
| $2.06M | ﹤0.01% |
174,486
+2,370
| +1% | +$26.7K |
2013 Q2
52 quarters
|
|
1394
The Greenbrier Companies
GBX
$1.18B
| $2.05M | ﹤0.01% |
41,788
-38,745
| -48% | -$1.9M |
2015 Q4
42 quarters
|
|
1395
HealthEquity
HQY
$8.6B
| $2.02M | ﹤0.01% |
22,390
-19,685
| -47% | -$1.67M |
2015 Q2
44 quarters
|
|
1396
Pacira BioSciences
PCRX
$1.45B
| $2.02M | ﹤0.01% |
79,703
-103,170
| -56% | -$2.44M |
2018 Q3
31 quarters
|
|
1397
Wolverine World Wide
WWW
$1.67B
| $2.02M | ﹤0.01% |
122,221
+37,330
| +44% | +$631K |
2013 Q2
52 quarters
|
|
1398
Huron Consulting
HURN
$3.11B
| $2.02M | ﹤0.01% |
22,398
+75
| +0.3% | +$8.59K |
2026 Q1
1 quarter
|
|
1399
LTC Properties
LTC
$2.36B
| $2.02M | ﹤0.01% |
52,509
+3,480
| +7% | +$132K |
2013 Q2
52 quarters
|
|
1400
NeoGenomics
NEO
$2.13B
| $2.02M | ﹤0.01% |
138,305
+1,840
| +1% | +$17.8K |
2019 Q1
29 quarters
|
|
Similar funds
Prudential Financial's Q2 2026 Portfolio in Review
As of Q2 2026, Prudential Financial held 2,616 positions worth $91.8B, up 13% from $81.2B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Prudential Financial's Q2 2026 filing shows 215 new, 1,225 increased, 1,002 reduced and 131 closed positions. Its largest new stake was National Healthcare Properties, Inc. Common Stock: 4,504,336 shares worth $66M. The largest sale was Dimensional US Equity ETF, an estimated $342M.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Financials.
- Prudential Financial's largest Q2 2026 buy was National Healthcare Properties, Inc. Common Stock: 4,504,336 shares worth $66M.
- Prudential Financial added most to PGIM AAA CLO ETF in Q2 2026, an estimated $422M increase.
- Prudential Financial's biggest Q2 2026 reduction was Dimensional US Equity ETF, cutting an estimated $342M.
- Prudential Financial fully exited Coterra Energy in Q2 2026, selling an estimated $13M.
- Prudential Financial's ten largest holdings make up 32% of its $91.8B portfolio in Q2 2026.
- Prudential Financial opened 215 new positions and closed 131 in Q2 2026.
- Prudential Financial's portfolio value rose 13% quarter-over-quarter to $91.8B.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.